Clinical trial NCT04904263: Advisory Board on Cancer, Infertility and Pregnancy
Official title: Advisory Board on Cancer, Infertility and Pregnancy
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Cancer in Pregnancy
Fertility Preservation
Cancer
Pregnancy
Keywords: Cancer in Pregnancy
Fertility preservation
Lead sponsor: University Hospital, Gasthuisberg
Sponsor class: OTHER
Collaborators: name: Kom Op Tegen Kanker
name: European Research Council
First posted: 2021-05-27
Enrollment: 100
Sex: FEMALE
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Advice can be requested regarding all patients with cancer during pregnancy, questions regarding patients with a fertility wish after cancer diagnosis or questions regarding patients with a postpartum cancer diagnosis

Brief summary: The Advisory Board on Cancer, Infertility and Pregnancy provides a platform where physicians from all over the world can request recommendations regarding the medical care of pregnant women diagnosed with cancer or regarding fertility preservation. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards.

To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

Detailed description: The Advisory Board on Cancer, Infertility and Pregnancy (ABCIP)-platform will be a web-based platform where clinicians from all over the world can request advice from a group of experts on the field of Cancer and Pregnancy. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards.

Clinicians can fill in a format (attached) requesting for advice, using only pseudonymized patient data after agreeing a disclaimer:

All information filled in in the 'request advice' format needs to be regarded as anonymous or pseudonymous data. We recommend you to inform your patient and ask for approval when needed, based on the rules and regulations applicable in your country.

The filled out request will be sent to the specific national board of their own country, and if no national board is available, to the overarching international board.

. To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

Eligibility criteria: Inclusion Criteria:

* Pregnant women with a cancer diagnosis
* Women with a fertility related question after cancer diagnosis
* Postpartum cancer diagnosis
* Cancer treatment during pregnancy

Primary outcomes:
measure: The impact of an international advisory board on cancer in pregnancy
timeFrame: 1 year
Secondary outcomes:
Other outcomes:
Locations:
city: Leuven
country: Belgium
facility: UZ Gasthuisberg, Katholieke Universiteit Leuven
Study officials:
affiliation: Universitaire Ziekenhuizen KU Leuven
name: Frederic Amant, MD,PhD
role: PRINCIPAL_INVESTIGATOR
References: